Loading ad...

Tzanck Test, Nikolsky Sign, and Bulla Spread Sign

Nikolsky Sign - Pathophysiology and Diagnostic Importance

The Nikolsky sign is an important clinical indicator of epidermal fragility seen in autoimmune and infectious dermatological conditions.

6/7/20255 min read49 views
loved it
normalintermediateDermatology, Venereology and Leprosy
Understanding Nikolsky Sign and Its Diagnostic Role

Tzanck Test, Nikolsky Sign, and Bulla Spread Sign

Nikolsky Sign - Pathophysiology and Diagnostic Importance

Nikolsky sign is a clinical dermatological finding indicating epidermal fragility. It is commonly observed in conditions like pemphigus vulgaris, toxic epidermal necrolysis (TEN), and staphylococcal scalded skin syndrome (SSSS).

Pathophysiology

The Nikolsky sign occurs due to the loss of cell-to-cell adhesion among keratinocytes, mediated by autoantibodies attacking desmosomal proteins such as desmoglein-1 and desmoglein-3.

Clinical Significance

  • Positive Nikolsky Sign: Gentle pressure on unaffected skin causes detachment of the epidermis.
  • Diagnostic Importance: Used to differentiate intraepidermal blistering conditions.

Tzanck Test

A rapid cytological test used for diagnosing viral infections such as herpes simplex virus and varicella-zoster virus.

Bulla Spread Sign

Indicates the lateral extension of a blister with gentle pressure, commonly seen in autoimmune blistering disorders.

Tags

#Nikolsky sign#Tzanck test#Bulla spread sign#dermatology#autoimmune diseases

0 people loved it

Recommended Reads

Explore related articles that might interest you

Tzanck Test, Nikolsky Sign, and Bulla Spread Sign
8
14%

Tzanck Test, Nikolsky Sign, and Bulla Spread Sign

Read more →
8
Pharmacological Management of Skin Disorders
38
12%

Pharmacological Management of Skin Disorders

Read more →
38
Cutaneous Manifestations of Systemic Lupus Erythematosus (SLE)
41
11%

Cutaneous Manifestations of Systemic Lupus Erythematosus (SLE)

Read more →
41
Etiopathogenesis, clinical presentation, and laboratory diagnosis of skin and soft tissue infections
33
11%

Etiopathogenesis, clinical presentation, and laboratory diagnosis of skin and soft tissue infections

Read more →
33
Indications and pharmacology of topical and systemic drugs for pyoderma treatment
4
11%

Indications and pharmacology of topical and systemic drugs for pyoderma treatment

Read more →
4
Etiopathogenesis, clinical presentation, and laboratory diagnosis of skin and soft tissue infections
36
11%

Etiopathogenesis, clinical presentation, and laboratory diagnosis of skin and soft tissue infections

Read more →
36
Pharmacology, administration, and adverse effects of pharmacological treatments for scabies
40
11%

Pharmacology, administration, and adverse effects of pharmacological treatments for scabies

Read more →
40
© 2025 MedGloss. All rights reserved.
Loading ad...